– USA, MA – AffyImmune Therapeutics, Inc., a clinical-stage biotechnology company using its Tune & Track platform to develop CAR T cells for the treatment of solid cancers, today announced the appointment of Robert Forrester to its Board of Directors, bringing decades of corporate leadership experience and an established track record of scaling startups from early stage to their growth phase.…
– USA, NY – Tally Health, an early-stage biotechnology company, today announced the appointment of Melanie Goldey to its Board of Directors as CEO, effective September 12, 2022.…
– CANADA, Vancouver – Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics, today announced the appointments of Dr.…
– GERMANY, Heilbronn – ProtaGene GmbH, a leading global contract research organization, today announced the appointment of Dr.…
– SWITZERLAND, Lausanne – HAYA Therapeutics, SA, a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs, today announced the appointment of Dr.…
